1. Home
  2. Analysis
  3. Repatha
  4. Fluocinonide

Repatha and Fluocinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Repatha (evolocumab) and Fluocinonide (fluocinonide). Common drug interactions include arteriosclerosis coronary artery among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Repatha and Fluocinonide. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

On Jul, 11, 2026

28 people who take Repatha and Fluocinonide together, and have interactions are studied.

Repatha and Fluocinonide drug interactions.

What are the common drug interactions of Repatha and Fluocinonide, by gender? *:

female:

  1. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  2. Cough
  3. Injection site bruising
  4. Injection site pruritus (severe itching at injection site)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Sinusitis (inflammation of sinus)
  7. Viral infection
  8. Drug ineffective
  9. Hospitalisation
  10. Intestinal obstruction

male:

  1. Diarrhoea
  2. Injection site mass
  3. Swelling
  4. Chest pain
  5. Dizziness
  6. Constipation
  7. Back pain
  8. Death
  9. Fall
  10. Heart valve replacement

What are the common drug interactions of Repatha and Fluocinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  2. Cough
  3. Intestinal obstruction

60+:

  1. Diarrhoea
  2. Injection site mass
  3. Back pain
  4. Drug ineffective
  5. Heart valve replacement
  6. Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
  7. Prostatic disorder
  8. Chest pain
  9. Dizziness
  10. Injection site bruising

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 14.29%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.71%
  3. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 7.14%
  4. Heart Disease: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and Fluocinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Repatha and Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluocinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repatha and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluocinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab and fluocinonide (the active ingredients of Repatha and Fluocinonide, respectively), and Repatha and Fluocinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.